Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
10000 participants
INTERVENTIONAL
2010-08-31
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction
NCT01708837
Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI
NCT03165396
Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol
NCT05533567
Sevoflurane and Propofol Anesthesia on Postoperative Delirium
NCT01995214
Postanesthesia Cognitive Recovery and Neuropsychologic Complications
NCT00507195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local anesthesia
Patients received local anesthesia without any intervention of general anesthetics
No interventions assigned to this group
Inhalational anesthesia
Patients received sevoflurane anesthesia during general anesthesia
Sevoflurane
1-8% sevoflurane for maintaining the whole period of general anesthesia
Intravenous anesthesia
Patients received intravenous anesthetic (Propofol) during general anesthesia
Propofol
1-4 mg/kg/h of propofol during the whole period of general anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane
1-8% sevoflurane for maintaining the whole period of general anesthesia
Propofol
1-4 mg/kg/h of propofol during the whole period of general anesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Without basal disorders of neurology and psychiatrics
Exclusion Criteria
* With chronic neurological disorders
* Cannot communicate with investigators
* Cannot stand general anesthesia
10 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fu Zhou Wang
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FuZhou Wang, PhD MD
Role: STUDY_DIRECTOR
Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NJFY7M12
Identifier Type: -
Identifier Source: secondary_id
NJMU-2010-07022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.